Table 1.
Allele | Gene | Frequency | P value | β ± SE | Explained variance (%) |
---|---|---|---|---|---|
A*02 | HLA-A | 0.306 | 4.07E-04 | 0.015 ± 0.004 | 0.010 |
B*07 | HLA-B | 0.030 | 6.89E-10 | 0.071 ± 0.011 | 0.029 |
B*08 | HLA-B | 0.009 | 1.53E-04 | 0.079 ± 0.021 | 0.011 |
B*13 | HLA-B | 0.110 | 4.37E-04 | 0.022 ± 0.006 | 0.009 |
B*46 | HLA-B | 0.100 | 1.10E-06 | 0.042 ± 0.009 | 0.032 |
B*58 | HLA-B | 0.057 | 3.75E-05 | 0.086 ± 0.021 | 0.080 |
C*07 | HLA-C | 0.176 | 5.09E-04 | 0.038 ± 0.011 | 0.042 |
DRB1*03 | HLA-DRB1 | 0.048 | 1.06E-07 | 0.048 ± 0.009 | 0.021 |
DRB1*04 | HLA-DRB1 | 0.113 | 6.15E-06 | 0.028 ± 0.006 | 0.016 |
DRB1*07 | HLA-DRB1 | 0.093 | 1.32E-08 | 0.041 ± 0.007 | 0.028 |
DRB1*09 | HLA-DRB1 | 0.145 | 9.76E-05 | 0.024 ± 0.006 | 0.014 |
DRB1*12 | HLA-DRB1 | 0.121 | 1.52E-09 | 0.047 ± 0.008 | 0.047 |
A*02:01 | HLA-A | 0.125 | 3.75E-06 | 0.035 ± 0.007 | 0.027 |
B*07:02 | HLA-B | 0.022 | 1.12E-07 | 0.089 ± 0.017 | 0.034 |
B*27:04 | HLA-B | 0.010 | 4.15E-05 | 0.113 ± 0.028 | 0.025 |
B*40:01 | HLA-B | 0.099 | 5.78E-05 | 0.038 ± 0.009 | 0.026 |
C*01:03 | HLA-C | 0.006 | 1.00E-04 | 0.182 ± 0.047 | 0.042 |
C*03:02 | HLA-C | 0.059 | 4.45E-08 | 0.085 ± 0.016 | 0.081 |
DQB1*03:02 | HLA-DQB1 | 0.057 | 1.94E-04 | 0.066 ± 0.018 | 0.047 |
DQB1*06:02 | HLA-DQB1 | 0.076 | 9.55E-06 | 0.122 ± 0.028 | 0.210 |
DRB1*03:01 | HLA-DRB1 | 0.048 | 1.11E-05 | 0.049 ± 0.011 | 0.022 |
DRB1*07:01 | HLA-DRB1 | 0.093 | 6.49E-06 | 0.040 ± 0.009 | 0.027 |
DRB1*12:02 | HLA-DRB1 | 0.082 | 5.13E-05 | 0.047 ± 0.012 | 0.033 |
Bold font indicates the HLA alleles with the strongest associations (P < 5.0 × 10−8). Significance is defined as P ≤ 0.0006 (0.05/72) for low-resolution alleles and P ≤ 0.0003 (0.05/163) for high-resolution HLA alleles based on a stringent Bonferroni correction. Explained variance (%) was estimated based on the effect sizes (β) and allele frequencies in CMDP. β ± SE is the regression slope and its SE.